About us
What we do
Our strategy
Market opportunity
Our team
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Financial calendar
Shareholder information
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Share price
INC 05.25 GBp
About us
What we do
Our strategy
Market opportunity
Our team
Board of Directors
Senior Management
Advisors and Founders
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Share price chart
Detailed share price
Financial calendar
Shareholder information
Shareholder Information
AGM
GM
Analyst coverage
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Corporate Governance Report
QCA Corporate Governance Principles
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
News
Home
News & media
News
Latest from Incanthera
News
2024
2023
2022
Archive
April 17th, 2024
Further re: Exercise of Warrants
View
April 9th, 2024
Exercise of Warrants
March 25th, 2024
Initiation of Analyst Research and Release of IGTV Coverage
March 25th, 2024
Commercial Update
View
March 25th, 2024
Incanthera plc - Breakthrough Distribution Deal
View
February 22nd, 2024
Grant of Options
Prev
2
3
4
Next